Common Shares Outstanding: The number of class A shares currently held by investors.
Perspective Therapeutics, Inc. (CATX) had Common Shares Outstanding of 114.09M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.08M |
|
$-26.79M |
|
-- |
|
$0.08M |
|
$29.34M |
|
$-29.26M |
|
$2.27M |
|
$-26.98M |
|
$-26.98M |
|
$-26.98M |
|
$-26.98M |
|
$-26.79M |
|
$-26.98M |
|
$-29.26M |
|
$-28.78M |
|
120.65M |
|
120.65M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$241.52M |
|
$107.80M |
|
$150.50M |
|
$392.02M |
|
$36.54M |
|
$1.54M |
|
$31.62M |
|
$68.16M |
|
$323.86M |
|
$283.86M |
|
$323.86M |
|
|
Common Shares Outstanding |
114.09M |
| Cash Flow Statement Financials | |
$-52.12M |
|
$-94.53M |
|
$164.51M |
|
$30.63M |
|
$48.49M |
|
$17.86M |
|
$5.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.61 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-36120.99% |
|
-36120.99% |
|
-- |
|
-33312.35% |
|
-33069.13% |
|
$-73.17M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.30 |
|
298.89 |
|
-8.33% |
|
-9.51% |
|
-6.88% |
|
-8.29% |
|
$2.84 |
|
$-0.61 |
|
$-0.43 |
|